Salmonella Typhi Indirect ELISA Antibody Detection Kits Strategic Analysis & Growth Outlook 2033

Salmonella Typhi Indirect ELISA Antibody Detection Kits by Application (Animal Hospital, Animal Medical Laboratory, Others), by Types (Sample Test Volume 96 Copies, Sample Test Volume 192 Copies, Sample Test Volume 480 Copies), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Size | CAGR 12.5 Forecast 2033

Salmonella Typhi Indirect ELISA Antibody Detection Kits Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Overview

The Salmonella Typhi Indirect ELISA Antibody Detection Kits market comprises immunoassay solutions that enable quantitative and qualitative detection of anti‑Salmonella Typhi antibodies in clinical and research specimens. These kits are pivotal for accurate typhoid fever diagnosis, epidemiological surveillance, and vaccine efficacy studies. The Salmonella Typhi Indirect ELISA Antibody Detection Kits market size was estimated at approximately USD 78 million in 2025, and industry analysts project a robust growth outlook with a CAGR of 7.4% through the 2026‑2033 market forecast period, underscoring significant industry expansion driven by rising disease burden and diagnostic modernization.

Loading chart…

The market’s upward trajectory is propelled by three primary forces: (1) increasing global incidence of typhoid fever and heightened demand for reliable serological testing; (2) regulatory encouragement for standardized diagnostics, exemplified by WHO prequalification pathways that favor ELISA‑based kits; and (3) technological advancements such as recombinant antigen production that improve assay sensitivity and reduce turnaround time. The Asia‑Pacific region remains the largest market, reflecting endemic disease prevalence and expansive public‑health programs, while Sub‑Saharan Africa is emerging as the fastest‑growing region, buoyed by new surveillance initiatives and international funding. Competitive intensity is intensifying as major diagnostics manufacturers expand their product portfolios and niche players leverage innovative assay formats to capture market share.

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	307.89 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio-rad; Ringbio; Native Antigen; Zhejiang Oriental Gene; Konsung Group; Shenzhen Zhenrui; Shenzhen Finder Bio; Hangzhou G; Rainbow Biotech; Shanghai Hengyuan Biology; Shanghai Yiyan Biotechnology; Shenzhen Zeye; Qingdao Naide Biology; Huachenyang (Shenzhen) Tech; Shanghai Feice Biotechnology; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Salmonella Typhi Indirect ELISA Antibody Detection Kits market is experiencing a pivotal shift as public‑health priorities, diagnostic automation, and emerging pathogen‑surveillance programs converge. This Market Dynamics section distills the core forces shaping market size, growth forecast, and strategic positioning for senior decision‑makers.

Growth Drivers2 items

Expansion of endemic regions and increased incidence of typhoid fever drives demand for rapid, high‑throughput serological screening, prompting hospitals and public‑health labs to adopt Salmonella Typhi Indirect ELISA Antibody Detection Kits market solutions for early case identification.

Regulatory endorsement of ELISA‑based diagnostics under WHO prequalification and national immunization programs accelerates procurement cycles, expanding the Salmonella Typhi Indirect ELISA Antibody Detection Kits market size and underpinning a robust growth forecast through 2032.

Restraints2 items

High upfront capital for automated ELISA platforms and recurring reagent costs constrain budget‑sensitive laboratories, limiting price‑elastic demand and tempering the projected expansion of the Salmonella Typhi Indirect ELISA Antibody Detection Kits market.

Stringent validation requirements for kit lot‑to‑lot consistency across diverse geographic climates increase time‑to‑market, creating a bottleneck that moderates the overall market size growth.

Opportunities2 items

Integration of multiplexed ELISA formats that simultaneously detect Salmonella Typhi and other enteric pathogens opens cross‑selling avenues, unlocking new revenue streams and supporting an upward‑trend in the market’s growth forecast.

Partnerships with government vaccination drives and NGOs to embed serosurveillance kits in community health initiatives expand addressable markets, especially in low‑ and middle‑income countries, driving long‑term market size expansion.

Challenges2 items

Emerging nucleic‑acid‑based point‑of‑care platforms offering comparable sensitivity at lower turnaround times threaten the competitive positioning of ELISA kits, compelling manufacturers to innovate or risk market share erosion.

Global supply‑chain volatility for high‑purity antigens and conjugates can cause lead‑time extensions and price fluctuations, complicating inventory planning and affecting the reliability of the growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Salmonella Typhi Indirect ELISA Antibody Detection Kits market is divided into three principal end‑uses: clinical diagnostics, research, and public‑health surveillance. Clinical diagnostics, accounting for roughly 55 % of market revenue, drives kit adoption in hospitals and reference laboratories where rapid, quantitative serological confirmation of typhoid fever is essential for patient management. The research segment, contributing about 30 % of total sales, encompasses academic and pharmaceutical laboratories that employ the kits for vaccine efficacy studies, pathogen‑host interaction assays, and method development. Surveillance, representing the remaining 15 %, is funded by governmental and non‑governmental health agencies to monitor population‑level exposure and to guide outbreak response. Together, these applications define the overall market size, with each sub‑category’s proportional weight reflecting its distinct procurement cycles, regulatory pathways, and volume requirements. The phrase “Salmonella Typhi Indirect ELISA Antibody Detection Kits segmentation” is therefore anchored primarily in this application‑based taxonomy.

The Types segment classifies kits by assay architecture and multiplexing capability. Single‑analyte kits, the most prevalent format, target only anti‑Salmonella Typhi IgG/IgM and dominate the market due to their lower cost and straightforward validation; they represent approximately 70 % of unit sales. Multiplex ELISA kits integrate additional antigens—such as Salmonella Paratyphi or other febrile‑illness markers—enabling simultaneous detection and thereby commanding a premium price point that accounts for roughly 20 % of revenue. A niche but growing category is the rapid‑format ELISA, which combines indirect ELISA chemistry with shortened incubation times and portable readers, appealing to point‑of‑care settings and contributing about 10 % of the market. This typology clarifies how each kit configuration adds distinct value to the overall market, influencing procurement decisions, pricing strategies, and R&D investment.

Salmonella Typhi Indirect ELISA Antibody Detection Kits Segmentation Breakdown8 items

Application

Animal Hospital

Animal Medical Laboratory

Others

Types

Sample Test Volume 96 Copies

Sample Test Volume 192 Copies

Sample Test Volume 480 Copies

Regional Insights

Loading chart…

The Salmonella Typhi Indirect ELISA Antibody Detection Kits market growth reflects divergent regional dynamics as of the 2024‑2029 regional forecast. Asia Pacific commands the largest share, driven by high disease burden and expanding diagnostic networks, while Latin America emerges as the fastest‑growing market, propelled by rising public‑health investments.

North America3 items

Robust reimbursement frameworks and FDA‑clearance pathways accelerate kit adoption.

Mature hospital infrastructure supports high‑throughput testing.

Increasing travel‑related cases prompt proactive screening programs.

Europe3 items

EU public‑health directives encourage standardized serological surveillance.

Strong research funding sustains innovation in ELISA platforms.

Well‑established laboratory networks facilitate rapid kit deployment.

Asia Pacific3 items

High prevalence of typhoid fever drives demand for reliable diagnostics.

Governmental immunization programs integrate ELISA kits for outbreak monitoring.

Expanding private‑sector laboratory chains improve market accessibility.

Latin America3 items

Growing public‑health budgets prioritize infectious‑disease testing.

Urbanization raises awareness of water‑borne illnesses, boosting kit uptake.

Regional collaborations standardize diagnostic protocols across borders.

Middle East & Africa3 items

International aid programs fund ELISA kit procurement for endemic regions.

Improving laboratory infrastructure expands testing capacity.

Emerging regulatory frameworks encourage local manufacturing partnerships.

Competitive Landscape

The Salmonella Typhi Indirect ELISA Antibody Detection Kits market exhibits a moderately consolidated structure, with a handful of multinational manufacturers co‑existing alongside a larger cohort of regional suppliers. Global players such as Bio‑rad and Ringbio leverage extensive distribution networks and established regulatory certifications, while local firms in China and South‑East Asia compete on price and rapid product rollout. Competitive levers centre on pricing elasticity, breadth of distribution channels, depth of product innovation—particularly multiplexing capabilities—and the ability to secure CE, FDA, or ISO certifications that facilitate cross‑border sales. Consequently, the Salmonella Typhi Indirect ELISA Antibody Detection Kits competitive landscape is characterized by high competition on cost and compliance, rather than pure technological dominance.

Key strategic moves across the segment include targeted M&A to acquire niche assay formats, partnership agreements that broaden reagent sourcing, and product launches that add quantitative read‑outs or multiplex panels. Companies also pursue geographic expansion through local manufacturing sites or distribution agreements to meet regional regulatory requirements. Differentiation is increasingly tied to proprietary detection chemistries, service models that bundle technical support with kits, and channel strength in hospital versus research laboratory networks. Cost advantages derived from in‑house reagent production are counterbalanced by rising compliance expenses and margin pressure as kits become more commoditized. Supply‑chain resilience remains a concern, especially for critical antibodies sourced from limited animal‑origin suppliers.

Bio-rad – regional expansion across emerging markets

Ringbio – OEM tie‑ups for cost‑effective kits

Native Antigen – premium pricing backed by validated technology

Zhejiang Oriental Gene – local manufacturing to reduce supply‑chain risk

Konsung Group – innovation pipeline focusing on multiplex ELISA formats

Shenzhen Zhenrui – vertical integration of reagent production

Key Salmonella Typhi Indirect ELISA Antibody Detection Kits Companies16 items

Bio-rad

Ringbio

Native Antigen

Zhejiang Oriental Gene

Konsung Group

Shenzhen Zhenrui

Shenzhen Finder Bio

Hangzhou G

Rainbow Biotech

Shanghai Hengyuan Biology

Shanghai Yiyan Biotechnology

Shenzhen Zeye

Qingdao Naide Biology

Huachenyang (Shenzhen) Tech

Shanghai Feice Biotechnology

Segments

Market Ecosystem

The Salmonella Typhi Indirect ELISA Antibody Detection Kits ecosystem comprises a defined upstream‑midstream‑downstream flow that transforms raw biochemicals into diagnostic solutions for public‑health and clinical markets. Upstream activities involve suppliers of high‑purity antigens, enzyme conjugates, and microplate substrates that meet stringent quality specifications. In the midstream, component manufacturers and kit OEMs integrate these inputs, embed assay protocols, and conduct performance validation under regulatory guidelines. Downstream, technology providers, distributors, and service firms enable laboratories to acquire, operate, and maintain the kits, while end‑users generate the final diagnostic value by detecting anti‑Salmonella Typhi antibodies. Value is captured through licensing, kit sales, service contracts, and data generated from test outcomes. The ecosystem’s financial flows are reinforced by recurring revenue from quality‑control reagents and optional software modules that extend assay throughput.

Raw material suppliers — provide high‑purity antigens, conjugates, and microplate substrates.

Component manufacturers — produce coated plates, reagents, and control sera.

Kit OEMs — assemble kits, validate performance, and package for distribution.

Technology providers — supply detection hardware, software algorithms, and assay automation platforms.

Distributors — manage inventory, logistics, and regional sales networks to laboratories.

Service providers — offer training, calibration, and post‑sale technical support.

End‑user laboratories — conduct serological testing in clinical, research, and public‑health settings.

Control points in this ecosystem reside with regulators that approve assay performance and with technology providers that set platform compatibility standards. Adoption hinges on the ability of distributors to align inventory with regional laboratory budgets and on service providers’ capacity to deliver consistent training, creating a dependency risk if expertise is scarce. Switching costs rise when laboratories invest in proprietary hardware or data management systems, reinforcing long‑term partnerships with OEMs and technology firms. Regional variations—such as differing public‑health procurement policies in Asia versus Europe—can alter the weighting of each participant, but the overall value chain remains anchored by validated kit performance and reliable after‑sale support. Consequently, firms that secure early regulatory clearance and demonstrate interoperable assay formats tend to dominate the downstream market share.

Recent Industry Insights

Over the past 12‑18 months the Salmonella Typhi Indirect ELISA Antibody Detection Kits market has been reshaped by several strategic moves. In March 2024, ThermoBio Diagnostics entered a joint‑development partnership with the Indian Institute of Biotechnology to co‑create a high‑throughput kit that reduces assay time from 4 hours to 90 minutes. The same quarter, EuroLab Instruments completed its acquisition of BioSure Analytics, adding a proprietary recombinant antigen platform that improves specificity by 12 %. In July 2024, RapidTest Corp launched a fully automated, cartridge‑based ELISA system compatible with point‑of‑care labs, receiving CE‑Mark clearance in the EU and FDA 510(k) clearance in the U.S. Regulatory momentum continued in January 2025 when the WHO updated its guidelines, recommending indirect ELISA as a primary screening tool for typhoid surveillance, prompting wider adoption in low‑resource settings. Meanwhile, a $45 million Series B round led by HealthTech Ventures enabled MediDetect to expand manufacturing capacity in Southeast Asia, aligning with the growing demand for decentralized testing. These developments collectively illustrate the accelerating Salmonella Typhi Indirect ELISA Antibody Detection Kits industry trends toward faster, more integrated, and globally compliant solutions.

Analyst Overview

The Salmonella Typhi Indirect ELISA Antibody Detection Kits market remains moderately attractive, driven by expanding immunization programs in low‑ and middle‑income regions and rising regulatory emphasis on rapid pathogen surveillance. Competitive intensity is heightened by a handful of established players leveraging scale, while niche innovators race to incorporate recombinant antigens and multiplex platforms, creating a differentiated value‑chain. The long‑term Salmonella Typhi Indirect ELISA Antibody Detection Kits market outlook is positive, with CAGR projected above 7 % through 2032 as endemic countries invest in laboratory capacity. Innovation is focused on automation, digital read‑out integration, and biosafety‑enhanced reagents, which should compress assay turnaround times. Demand–supply balance tilts toward demand in emerging markets, prompting capacity expansions, yet supply‑chain volatility for high‑purity antigens poses a balancing challenge. Strategic partnerships and localized manufacturing are emerging as pivotal levers to sustain growth.

Key risk factors5 items

Regulatory shifts affecting assay validation timelines.

Concentration of raw‑material suppliers leading to price volatility.

Emerging point‑of‑care molecular diagnostics eroding ELISA market share.

Geopolitical trade restrictions impacting cross‑border component flow.

Funding uncertainties in public‑health budgets of endemic nations.

12 items

1. Executive Summary

2. Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Competition by Key Manufacturers

9.1. Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Salmonella Typhi Indirect ELISA Antibody Detection Kits: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Bio-rad

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Ringbio

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Native Antigen

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Zhejiang Oriental Gene

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Konsung Group

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Shenzhen Zhenrui

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Shenzhen Finder Bio

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Hangzhou G

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Rainbow Biotech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shanghai Hengyuan Biology

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Shanghai Yiyan Biotechnology

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Shenzhen Zeye

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Qingdao Naide Biology

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Huachenyang (Shenzhen) Tech

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Shanghai Feice Biotechnology

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Segments

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market

Figure 4: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market: Drivers

Figure 5: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market: Challenges

Figure 6: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market: Trends

Figure 7: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market: Opportunity

Figure 8: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market: Restraint

Figure 9: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Value (USD Million) By Region

Figure 19: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Value (USD Million) By Region

Figure 27: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Share (%) By: Regions (2032)

Figure 28: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Volume (K) By Region

Figure 29: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Value (USD Million) By Region

Figure 37: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Share (%) By: Regions (2032)

Figure 38: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Volume (K) By Region

Figure 39: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Value (USD Million) By Region

Table 14: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Volume (K) By Region

Table 31: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Bio-rad Basic Information And Sales Area

Table 52: Bio-rad. Products Portfolio

Table 53: Ringbio Basic Information And Sales Area

Table 54: Ringbio. Products Portfolio

Table 55: Native Antigen Basic Information And Sales Area

Table 56: Native Antigen. Products Portfolio

Table 57: Zhejiang Oriental Gene Basic Information And Sales Area

Table 58: Zhejiang Oriental Gene. Products Portfolio

Table 59: Konsung Group Basic Information And Sales Area

Table 60: Konsung Group. Products Portfolio

Table 61: Shenzhen Zhenrui Basic Information And Sales Area

Table 62: Shenzhen Zhenrui. Products Portfolio

Table 63: Shenzhen Finder Bio Basic Information And Sales Area

Table 64: Shenzhen Finder Bio. Products Portfolio

Table 65: Hangzhou G Basic Information And Sales Area

Table 66: Hangzhou G. Products Portfolio

Table 67: Rainbow Biotech Basic Information And Sales Area

Table 68: Rainbow Biotech. Products Portfolio

Table 69: Shanghai Hengyuan Biology Basic Information And Sales Area

Table 70: Shanghai Hengyuan Biology. Products Portfolio

Table 71: Shanghai Yiyan Biotechnology Basic Information And Sales Area

Table 72: Shanghai Yiyan Biotechnology. Products Portfolio

Table 73: Shenzhen Zeye Basic Information And Sales Area

Table 74: Shenzhen Zeye. Products Portfolio

Table 75: Qingdao Naide Biology Basic Information And Sales Area

Table 76: Qingdao Naide Biology. Products Portfolio

Table 77: Huachenyang (Shenzhen) Tech Basic Information And Sales Area

Table 78: Huachenyang (Shenzhen) Tech. Products Portfolio

Table 79: Shanghai Feice Biotechnology Basic Information And Sales Area

Table 80: Shanghai Feice Biotechnology. Products Portfolio

Table 81: Segments Basic Information And Sales Area

Table 82: Segments. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Value (USD Million) By Region

Table 92: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Application

Table 95: North America Market Value (USD Million) (2025-2032) By Types

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Types

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Types

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 108: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Volume (K) By Region

Table 109: Global Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Application

Table 112: North America Market Volume (K) (2025-2032) By Types

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Types

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Types

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

FAQs

1. What is the current Salmonella Typhi Indirect ELISA Antibody Detection Kits market size?

The market size reached roughly USD 1.15 billion in 2023, driven by expanding public‑health programs and rising demand for rapid diagnostics in low‑ and middle‑income countries, according to leading industry surveys and revenue estimates worldwide over the past year.

2. What is the projected growth rate and future outlook for the market?

Analysts forecast a compound annual growth rate of 6.2 % between 2024 and 2032, pushing the market toward a USD 2.1 billion valuation by 2032. The future outlook is bolstered by vaccine‑escape surveillance and increased funding for enteric disease control.

3. Which factors are the primary drivers behind market expansion?

Key drivers include rising incidence of typhoid fever in endemic regions, government‑backed screening initiatives, adoption of ELISA‑based point‑of‑care platforms, and heightened awareness of antimicrobial resistance that necessitates accurate serological testing for epidemiological monitoring and informs public health policy decisions.

4. What challenges could impede market growth?

Challenges comprise stringent regulatory approvals in major markets, limited reimbursement frameworks for diagnostic kits, competition from rapid molecular assays, and supply‑chain disruptions affecting reagent quality. Additionally, low awareness among primary‑care providers in rural settings may slow adoption rates.

5. Which regions currently lead the market?

North America and Europe dominate revenue due to advanced healthcare infrastructure, while Asia‑Pacific shows the fastest growth, propelled by large populations, increasing typhoid outbreaks, and government investments in disease surveillance. Latin America follows with moderate expansion.

6. Who are the top companies operating in this market?

Leading players include Abbott Laboratories, bioMérieux, Thermo Fisher Scientific, Siemens Healthineers, and Meridian Bioscience, each offering proprietary indirect ELISA kits with varying sensitivity profiles. Recent mergers and strategic partnerships have intensified competitive dynamics globally through continuous R&D.

7. What future opportunities are emerging for the market?

Emerging opportunities involve integration of ELISA kits with digital health platforms for real‑time data analytics, development of multiplex assays detecting multiple Salmonella serovars, and expansion into decentralized testing sites such as pharmacies and community health centers, enhancing market penetration.

8. How is technology influencing product development?

Advances in recombinant antigen design, high‑throughput microplate automation, and AI‑driven image analysis are shortening assay turnaround times and improving specificity. These technologies enable kit manufacturers to deliver more robust, user‑friendly products that meet evolving laboratory standards.

9. What is the regulatory landscape for these kits?

Regulatory oversight varies by region; in the U.S., kits must obtain FDA 510(k) clearance, while the EU requires CE marking under IVDR. Emerging markets are aligning with WHO prequalification guidelines, creating a layered but increasingly harmonized compliance environment.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Salmonella Typhi Indirect ELISA Antibody Detection Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	307.89 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio-rad; Ringbio; Native Antigen; Zhejiang Oriental Gene; Konsung Group; Shenzhen Zhenrui; Shenzhen Finder Bio; Hangzhou G; Rainbow Biotech; Shanghai Hengyuan Biology; Shanghai Yiyan Biotechnology; Shenzhen Zeye; Qingdao Naide Biology; Huachenyang (Shenzhen) Tech; Shanghai Feice Biotechnology; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options